Literature DB >> 20208144

Relevance of germline mutation screening in both familial and sporadic head and neck paraganglioma for early diagnosis and clinical management.

Mario A Hermsen1, María A Sevilla, José Luis Llorente, Marjan M Weiss, Anneliese Grimbergen, Eva Allonca, Cristina Garcia-Inclán, Milagros Balbín, Carlos Suárez.   

Abstract

BACKGROUND: Head and neck paraganglioma (PGL) are benign tumors that can cause important direct or surgery induced morbidity. Almost all familial and 11-29% of sporadic PGL are caused by inactivating germline mutations in succinate dehydrogenase (SDH) genes. Our aim was to screen for such mutations and to evaluate clinical parameters as predictors of germline mutation.
METHODS: Seventy-four PGL patients were analyzed for germline mutations and large deletions in SDH genes, VHL and RET. Results were correlated to clinical characteristics including gender, age, tumor localization and multifocality. The surgical approach was evaluated in terms of tumor origin, sequelae and subsequent evolution.
RESULTS: Mutations in SDHB and SDHD were identified in equal proportion in 13/13 (100%) of familial and in 15/61 (25%) of sporadic cases. Familiarity, age < or =50 years and male gender were predictors of any germline mutation, while multifocality and carotid/vagal localization were indicative of SDHD mutation in particular.
CONCLUSION: In contrast to other series, this cohort of Spanish patients showed many SDHB mutations. Sporadic cases with germline mutation are frequent and underline the importance of mutational screening of all PGL patients, allowing the identification of relatives at risk and the early diagnosis of the disease, reducing or avoiding morbidity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20208144      PMCID: PMC4619289          DOI: 10.3233/CLO-2009-0498

Source DB:  PubMed          Journal:  Cell Oncol        ISSN: 1570-5870            Impact factor:   6.730


  10 in total

1.  [Endocrine surgery for neck paraganglioma: operation, radiation therapy or wait and scan?].

Authors:  R Schneider; J Ukkat; P Nguyen-Thanh; K Lorenz; S Plontke; C Behrmann; C Sekulla; H Dralle
Journal:  Chirurg       Date:  2012-12       Impact factor: 0.955

2.  Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors.

Authors:  Bruna Babic; Dhaval Patel; Rachel Aufforth; Yasmine Assadipour; Samira M Sadowski; Martha Quezado; Naris Nilubol; Tamara Prodanov; Karel Pacak; Electron Kebebew
Journal:  Surgery       Date:  2016-11-16       Impact factor: 3.982

3.  Carotid body tumor encounters over a two-decade period in an academic hospital.

Authors:  Abdulmajeed Altoijry; Hesham Alghofili; Kaisor Iqbal; Talal Altuwaijri; Badr Aljabri; Mussaad Al-Salman
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

4.  Genetic testing in head and neck paraganglioma: who, what, and why?

Authors:  Shankar K Sridhara; Murat Yener; Ehab Y Hanna; Thereasa Rich; Camilo Jimenez; Michael E Kupferman
Journal:  J Neurol Surg B Skull Base       Date:  2013-04-12

5.  A two-decade experience of head and neck paragangliomas in a whole population-based single centre cohort.

Authors:  T Anttila; V Häyry; T Nicoli; J Hagström; K Aittomäki; P Vikatmaa; M Niemelä; K Saarilahti; A Mäkitie; L J Bäck
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-29       Impact factor: 2.503

6.  Evolving management strategies in head and neck paragangliomas: A single-centre experience with 147 patients over a 60-year period.

Authors:  J A Rijken; B de Vos; L P van Hest; K M A Dreijerink; M den Heijer; W Wisselink; G J Blom; E F Hensen; C R Leemans
Journal:  Clin Otolaryngol       Date:  2019-06-26       Impact factor: 2.597

Review 7.  Clinical Practice Guidance: Surveillance for phaeochromocytoma and paraganglioma in paediatric succinate dehydrogenase gene mutation carriers.

Authors:  Mei Yin Wong; Katrina A Andrews; Benjamin G Challis; Soo-Mi Park; Carlo L Acerini; Eamonn R Maher; Ruth T Casey
Journal:  Clin Endocrinol (Oxf)       Date:  2019-01-29       Impact factor: 3.478

8.  Genetic screening for monogenic hypertension in hypertensive individuals in a clinical setting.

Authors:  Minghui Bao; Ping Li; Qifu Li; Hui Chen; Ying Zhong; Shuangyue Li; Ling Jin; Wenjie Wang; Zhenzhen Chen; Jiuchang Zhong; Bin Geng; Yuxin Fan; Xinchun Yang; Jun Cai
Journal:  J Med Genet       Date:  2020-06-19       Impact factor: 6.318

9.  Genetic Variants in Patients with Multiple Head and Neck Paragangliomas: Dilemma in Management.

Authors:  Anasuya Guha; Ales Vicha; Tomas Zelinka; Zdenek Musil; Martin Chovanec
Journal:  Biomedicines       Date:  2021-05-31

10.  Immunohistochemistry and Mutation Analysis of SDHx Genes in Carotid Paragangliomas.

Authors:  Anastasiya V Snezhkina; Dmitry V Kalinin; Vladislav S Pavlov; Elena N Lukyanova; Alexander L Golovyuk; Maria S Fedorova; Elena A Pudova; Maria V Savvateeva; Oleg A Stepanov; Andrey A Poloznikov; Tatiana B Demidova; Nataliya V Melnikova; Alexey A Dmitriev; George S Krasnov; Anna V Kudryavtseva
Journal:  Int J Mol Sci       Date:  2020-09-22       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.